IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $927,204 | -10.8% | 20,441 | -13.1% | 0.00% | 0.0% |
Q3 2022 | $1,040,000 | -11.3% | 23,517 | -20.0% | 0.00% | -33.3% |
Q2 2021 | $1,172,000 | +332.5% | 29,382 | +512.1% | 0.00% | +200.0% |
Q4 2020 | $271,000 | -50.5% | 4,800 | -48.4% | 0.00% | -50.0% |
Q2 2020 | $548,000 | +17.1% | 9,300 | -6.0% | 0.00% | 0.0% |
Q1 2020 | $468,000 | +2240.0% | 9,895 | +2889.4% | 0.00% | – |
Q4 2019 | $20,000 | -37.5% | 331 | -38.5% | 0.00% | – |
Q3 2019 | $32,000 | -98.6% | 538 | -98.5% | 0.00% | -100.0% |
Q2 2019 | $2,246,000 | -84.9% | 34,939 | -81.0% | 0.01% | -85.7% |
Q1 2019 | $14,919,000 | -22.0% | 183,800 | -48.1% | 0.08% | -35.3% |
Q4 2018 | $19,138,000 | +71.6% | 354,023 | +63.7% | 0.12% | +58.7% |
Q3 2018 | $11,152,000 | -0.7% | 216,202 | -19.8% | 0.08% | +8.7% |
Q2 2018 | $11,229,000 | +9.0% | 269,474 | +15.3% | 0.07% | -15.9% |
Q1 2018 | $10,306,000 | -13.1% | 233,800 | -0.8% | 0.08% | -6.8% |
Q4 2017 | $11,861,000 | +52.2% | 235,800 | +53.4% | 0.09% | +41.9% |
Q3 2017 | $7,793,000 | – | 153,700 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |